A complicated case of community acquired pneumonia: Beware of drug induced side effects in critically ill people by Johnson, SR, Pavord, I, Tattersfield, A, Macfarlane, J, Donald, F, Ahsan, A, Banks, D, Loudon, M

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis. by Elliott, M, Maini, R, Feldmann, M, Kalden, JR, Antoni, C, Smolen, J, Leeb, B, Breedveld, F, Macfarlane, J, Bijl, H

Immunogenicity and safety of PRP-T conjugate vaccine given according to the British accelerated immunisation schedule. by Booy, R, Taylor, SA, Dobson, SR, Isaacs, D, Sleight, G, Aitken, S, Griffiths, H, Chapel, H, Mayon-White, RT, Macfarlane, J

Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis. by Maini, R, Breedveld, F, Kalden, JR, Smolen, J, Davis, D, Macfarlane, J, Antoni, C, Leeb, B, Elliott, M, Woody, J, Schaible, T, Feldmann, M

Serogroup-specific epidemiology of Streptococcus pneumoniae: associations with age, sex, and geography in 7,000 episodes of invasive disease. by Scott, J, Hall, A, Dagan, R, Dixon, J, Eykyn, S, Fenoll, A, Hortal, M, Jetté, L, Jorgensen, J, Lamothe, F, Latorre, C, Macfarlane, J, Shlaes, D, Smart, L, Taunay, A